Filing Details
- Accession Number:
- 0001447348-12-000040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-03 14:19:36
- Reporting Period:
- 2012-07-02
- Filing Date:
- 2012-07-03
- Accepted Time:
- 2012-07-03 13:19:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
835887 | Progenics Pharmaceuticals Inc | PGNX | Pharmaceutical Preparations (2834) | 133379479 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1250274 | J Robert Israel | 777 Old Saw Mill River Road Tarrytown NY 10591 | Senior Vp Medical Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-02 | 1,000 | $5.33 | 36,050 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-07-02 | 1,000 | $9.79 | 35,050 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-07-02 | 1,000 | $9.79 | 1,000 | $5.33 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,000 | 2010-07-01 | 2019-07-01 | No | 4 | M | Direct |
Footnotes
- The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer.
- The stock options become exercisable in three equal annual installments, commencing one year from the grant date.